New shot could tame high blood pressure without daily pills
NCT ID NCT04936035
First seen Jan 11, 2026 · Last updated May 13, 2026 · Updated 20 times
Summary
This study tested an experimental drug called ALN-AGT01 in 394 adults with mild-to-moderate high blood pressure. The goal was to see if it could safely lower blood pressure readings over 24 hours and in the doctor's office. Participants received either the drug or a placebo, and their blood pressure was measured at 3 months.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERTENSION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Clinical Trial Site
Birmingham, Alabama, 35209, United States
-
Clinical Trial Site
Tempe, Arizona, 85281, United States
-
Clinical Trial Site
Tempe, Arizona, 85282, United States
-
Clinical Trial Site
Beverly Hills, California, 90211, United States
-
Clinical Trial Site
La Mesa, California, 91942, United States
-
Clinical Trial Site
Los Angeles, California, 90057, United States
-
Clinical Trial Site
San Diego, California, 92103, United States
-
Clinical Trial Site
South Gate, California, 90280, United States
-
Clinical Trial Site
Vista, California, 92083, United States
-
Clinical Trial Site
Washington D.C., District of Columbia, 20011, United States
-
Clinical Trial Site
Clearwater, Florida, 33756, United States
-
Clinical Trial Site
Coral Gables, Florida, 33134, United States
-
Clinical Trial Site
Fleming Island, Florida, 32003, United States
-
Clinical Trial Site
Hollywood, Florida, 33021, United States
-
Clinical Trial Site
Hollywood, Florida, 33024, United States
-
Clinical Trial Site
Inverness, Florida, 34452, United States
-
Clinical Trial Site
Jacksonville, Florida, 32204, United States
-
Clinical Trial Site
Jacksonville, Florida, 32216, United States
-
Clinical Trial Site
Jacksonville, Florida, 32256, United States
-
Clinical Trial Site
Miami, Florida, 33126, United States
-
Clinical Trial Site
Miami, Florida, 33135, United States
-
Clinical Trial Site
Naples, Florida, 34102, United States
-
Clinical Trial Site
Orlando, Florida, 32801, United States
-
Clinical Trial Site
Acworth, Georgia, 30101, United States
-
Clinical Trial Site
Columbus, Georgia, 31904, United States
-
Clinical Trial Site
Fayetteville, Georgia, 30214, United States
-
Clinical Trial Site
Macon, Georgia, 31210, United States
-
Clinical Trial Site
Champaign, Illinois, 61822, United States
-
Clinical Trial Site
Valparaiso, Indiana, 46383, United States
-
Clinical Trial Site
West Des Moines, Iowa, 50266, United States
-
Clinical Trial Site
Lake Charles, Louisiana, 70601, United States
-
Clinical Trial Site
New Orleans, Louisiana, 70124, United States
-
Clinical Trial Site
Prairieville, Louisiana, 70769, United States
-
Clinical Trial Site
Baltimore, Maryland, 21229, United States
-
Clinical Trial Site
Jackson, Mississippi, 39209, United States
-
Clinical Trial Site
Jefferson City, Missouri, 65109, United States
-
Clinical Trial Site
Las Vegas, Nevada, 89119, United States
-
Clinical Trial Site
New York, New York, 10036, United States
-
Clinical Trial Site
The Bronx, New York, 10456, United States
-
Clinical Trial Site
Greensboro, North Carolina, 27408, United States
-
Clinical Trial Site
Greensboro, North Carolina, 27410, United States
-
Clinical Trial Site
Medford, Oregon, 97504, United States
-
Clinical Trial Site
Greenville, South Carolina, 29607, United States
-
Clinical Trial Site
Memphis, Tennessee, 38119, United States
-
Clinical Trial Site
Cedar Park, Texas, 78613, United States
-
Clinical Trial Site
Houston, Texas, 77074, United States
-
Clinical Trial Site
Houston, Texas, 77081, United States
-
Clinical Trial Site
Magnolia, Texas, 77355, United States
-
Clinical Trial Site
Pearland, Texas, 77584, United States
-
Clinical Trial Site
San Antonio, Texas, 78229, United States
-
Clinical Trial Site
Stephenville, Texas, 76401, United States
-
Clinical Trial Site
Tomball, Texas, 77375, United States
-
Clinical Trial Site
Waco, Texas, 76708, United States
-
Clinical Trial Site
Burke, Virginia, 22015, United States
-
Clinical Trial Site
Red Deer, Alberta, Canada
-
Clinical Trial Site
New Minas, Nova Scotia, Canada
-
Clinical Trial Site
Brampton, Ontario, Canada
-
Clinical Trial Site
Toronto, Ontario, Canada
-
Clinical Trial Site
Chicoutimi, Quebec, Canada
-
Clinical Trial Site
Mirabel, Quebec, Canada
-
Clinical Trial Site
Montreal, Quebec, Canada
-
Clinical Trial Site
Québec, Quebec, Canada
-
Clinical Trial Site
Trois-Rivières, Quebec, Canada
-
Clinical Trial Site
Victoriaville, Quebec, Canada
-
Clinical Trial Site
Bayamón, 00961, Puerto Rico
-
Clinical Trial Site
Ponce, 00716, Puerto Rico
-
Clinical Trial Site
San Juan, Puerto Rico
-
Clinical Trial Site
Ivano-Frankivsk, Ukraine
-
Clinical Trial Site
Kharkiv, Ukraine
-
Clinical Trial Site
Odesa, Ukraine
-
Clinical Trial Site
Uzhhorod, Ukraine
-
Clinical Trial Site
Glasgow, United Kingdom
-
Clinical Trial Site
Hexham, United Kingdom
-
Clinical Trial Site
London, United Kingdom
-
Clinical Trial Site
Manchester, United Kingdom
Conditions
Explore the condition pages connected to this study.